According to GlaxoSmithKline's latest financial reports the company's current earnings are HK$40.25 Billion. In 2023 the company made an earning of HK$58.65 Billion, an increase over its 2022 earnings that were of HK$53.98 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.